Denali Therapeutics (NASDAQ:DNLI) reported its Q4 earnings results on Tuesday, February 27, 2024 at 08:05 AM.

Here's what investors need to know about the announcement.

Earnings

Denali Therapeutics missed estimated earnings by -7.000000000000001%, reporting an EPS of $-0.86 versus an estimate of $-0.8.

Revenue was down $10.28 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 5.0% drop in the share price the next day.

Here's a look at Denali Therapeutics's past performance:

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Denali Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.